摘要
目的探讨美托洛尔联合曲美他嗪治疗冠心病心力衰竭患者临床疗效。方法 328例患者被随机分为实验组和对照组,两组均给予综合治疗,实验组在常规治疗基础上给予美托洛尔和曲美他嗪联合治疗。结果治疗后,实验组治疗效果和心功能改善等方面均显著优于对照组(P<0.05)。结论在综合治疗的基础上,曲美他嗪和美托洛尔联合使用,能达到更为显著的治疗效果,是值得临床考虑的治疗方案之一。
Objective To explore the clinical effect of metoprolol combined with trimetazidine used for coronary disease combined with cardiac failure.Methods 328 cases of patients were randomly divided into experimental group and control group.Both groups were given comprehensive therapy,and experimental group were added to therapy of metoprolol combined with trimetazidine.Results After therapy,he clinical effect and heart function in experimental group were significantly better than that in control group（P 0.05）.Conclusion Metoprolol combined with trimetazidine used for patients on base of comprehensive therapy,can reached up more significant clinical effect,so it is one of the desirable therapy method in clinical work.
出处
《当代医学》
2011年第12期8-9,共2页
Contemporary Medicine
关键词
冠心病
心力衰竭
美托洛尔
曲美他嗪
Coronary disease
Cardiac failure
Metoprolol
Trimetazidine
